Latest stories on GOVX
GeoVax Stockholders Approve Warrants and Reverse Split
TipRanks42 · neutralgeneral
GeoVax Labs, Inc. (GOVX) files 8-K
SEC 8-K50 · neutralgeneral
EQS-News: Update - GeoVax Enters Into $1 Million Revolving Loan Agreement
Business Insider52 · neutralgeneral
EQS-News: GeoVax Enters Into $1 Million Revolving Loan Agreement
Business Insider52 · neutralgeneral
EQS-News: GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026
Business Insider63 · neutralproduct/pr
EQS-News: GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United States
Business Insider55 · neutralgeneral
EQS-News: GeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical Models
Business Insider67 · bullishproduct/pr
EQS-News: GeoVax Confirms Bundibugyo Ebola Vaccine Construct
Business Insider63 · neutralproduct/pr
EQS-News: GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial
Business Insider56 · neutralproduct/pr
GeoVax Labs, Inc. (GOVX) files 8-K
SEC 8-K50 · neutralgeneral
EQS-News: GeoVax Provides Nasdaq Listing Update and Reaffirms Focus on Advancing Strategic Priorities
Business Insider55 · neutralgeneral
GeoVax Labs, Inc. (GOVX) files 8-K
SEC 8-K34 · bearishgeneral
GeoVax Labs, Inc. (GOVX) files 8-K
SEC 8-K50 · neutralgeneral
EQS-News: GeoVax Advances GEO-MVA Toward Pivotal Phase 3 Study Implementation
Business Insider63 · neutralproduct/pr
EQS-News: GeoVax Initiates Global Health Outreach to WHO, Africa CDC and Other Agencies Regarding Ebola Vaccine Portfolio Amid Expanding Outbreak
Business Insider58 · neutralproduct/pr
EQS-News: GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies
Business Insider67 · bullishproduct/pr
EQS-News: GeoVax Chairman and CEO David Dodd to Participate in 2026 Georgia Life Sciences Summit
Business Insider50 · neutralgeneral
EQS-News: GeoVax Highlights Capabilities Amid Congo's Expanding Ebola Outbreak
Business Insider58 · neutralgeneral
EQS-News: GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase
Business Insider63 · neutralproduct/pr
EQS-News: GeoVax Announces Completion of Key GEO-MVA Development Milestones, Positioning Program for Pivotal Phase 3 Clinical Study
Business Insider63 · neutralproduct/pr
Geovax Labs Risk Profile Appears Stable, But Investors Should Watch for Emerging SEC-Disclosed Pressures
TipRanks48 · neutralgeneral
GeoVax GAAP EPS of -$0.97 beats by $1.18
Seeking Alpha58 · neutralearnings
GeoVax Labs, Inc. (GOVX) files 8-K
SEC 8-K50 · neutralgeneral
EQS-News: GeoVax Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Insider55 · neutralearnings